PT Journal
AU Stejskal, D
   Bartek, J
   Pastorkova, R
   Ruzicka, V
   Oral, I
   Horalik, D
TI OSTEOPROTEGERIN, RANK, RANKL
SO Biomedical papers
PY 2001
BP 61
EP 64
VL 145
IS 2
DI 10.5507/bp.2001.013
DE Osteoprotegerin / RANK / RANKL
AB Osteoprotegerin, RANK (Receptor Activator of Nuclear factor kappa B) and RANKL (Receptor Activator ofNuclear faktor kappa B ligand) became the aim of intensive researche. RANK is considered as a hematopoieticsurface receptor controling osteoclastogenesis and calcium metabolism. RANKL may promote osteoresorption byinduction of cathepsin K gene expression. The present paper summarizes the most significant data in osteoprotegerin,RANK and RANKL problems obtained.
ER